F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC – Get Free Report) was the target of a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 5,613 shares, a decline of 77.2% from the September 15th total of 24,651 shares. Based on an average daily trading volume, of 3,199 shares, the short-interest ratio is presently 1.8 days. Currently, 0.2% of the shares of the company are sold short.
Institutional Trading of F/m Emerald Life Sciences Innovation ETF
An institutional investor recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC raised its holdings in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC – Free Report) by 8.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the period. Hunter Associates Investment Management LLC owned about 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent quarter.
F/m Emerald Life Sciences Innovation ETF Price Performance
Shares of LFSC traded up $0.94 during trading hours on Friday, reaching $42.61. 561 shares of the company traded hands, compared to its average volume of 4,316. The business has a fifty day moving average price of $45.74 and a 200-day moving average price of $42.06. F/m Emerald Life Sciences Innovation ETF has a 12-month low of $29.44 and a 12-month high of $48.78.
About F/m Emerald Life Sciences Innovation ETF
The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.
Featured Stories
- Five stocks we like better than F/m Emerald Life Sciences Innovation ETF
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
- Why Wall Street Expects Even More From SanDisk After Its 575% Rally
Receive News & Ratings for F/m Emerald Life Sciences Innovation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for F/m Emerald Life Sciences Innovation ETF and related companies with MarketBeat.com's FREE daily email newsletter.
